Name: Greenwich LifeSciences, Inc. (GLSI) Financial Statements
Creator: FinSpry

Greenwich LifeSciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Greenwich LifeSciences, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	12.95	7.70	6.48	3.56	1.06
Selling, General & Administrative	3.06	1.63	1.56	1.04	0.81
Operating Expenses	16.01	9.33	8.04	4.60	1.86
Operating Income	-16.01	-9.33	-8.04	-4.60	-1.86
Other Income/Expense
Interest Income	0.22	0.44	0.22	0.03	0.00
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	0.22	0.00	0.00	0.00	0.00
Income
Income Before Tax	-15.79	-8.89	-7.83	-4.57	-1.86
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-15.79	-8.89	-7.83	-4.57	-1.86
Net Income - Continuous Operations	-15.79	-8.89	-7.83	-4.57	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-16.01	-9.32	-8.04	-4.59	-1.86
EBIT	-16.01	-9.33	-8.04	-4.60	-1.86
Depreciation & Amortization	0.00	0.00	0.00	0.00	0.00
Earnings Per Share
Basic EPS	-1.00	-1.00	-1.00	-	-
Diluted EPS	-1.00	-1.00	-1.00	-	-
Basic Shares Outstanding	13.01	12.85	12.91	12.94	9.50
Diluted Shares Outstanding	13.01	12.85	12.91	12.94	9.50